Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Koninklijke Porceleyne Fles | PORF | Sep 19, 2024 | 13.40 | 0.00 |
Koninklijke Vopak NV | VPK | Sep 19, 2024 | 41.94 | -1.69 |
Lavide Holding NV | LVIDE | Sep 19, 2024 | 0.32 | +6.00 |
Marel | MAREL | Sep 19, 2024 | 3.33 | +0.91 |
Midkap-index | AMX | Sep 19, 2024 | 901.24 | +1.77 |
MKB Nedsense | NEDSE | Sep 19, 2024 | 0.06 | +2.42 |
Morefield Group | MORE | Sep 19, 2024 | 0.53 | 0.00 |
MotorK Plc | MTRK | Sep 19, 2024 | 5.80 | 0.00 |
Nedap N.V. | NEDAP | Sep 19, 2024 | 57.20 | +0.70 |
Nederlandse Beleggingsmaatschappij Voor Zeeschepen NV | NBZ | Sep 19, 2024 | 1.00 | 0.00 |
NEPI Rockcastle N.V. | NRP | Sep 19, 2024 | 7.55 | +2.72 |
New Amsterdam Invest N.V. | NAI | Sep 19, 2024 | 8.00 | 0.00 |
New Sources Energy NV | NSE | Sep 19, 2024 | 0.02 | 0.00 |
Next 150 | N150 | Sep 19, 2024 | 3 375.76 | +1.44 |
NN Group NV | NN | Sep 19, 2024 | 44.96 | +1.63 |
NSI N.V. | NSI | Sep 19, 2024 | 20.90 | +0.97 |
NX Filtration N.V. | NXFIL | Sep 19, 2024 | 4.50 | +0.90 |
OCI N.V. Shs (Netherlands) | OCI | Sep 19, 2024 | 26.70 | +1.41 |
Onward Medical NV | ONWD | Sep 19, 2024 | 4.90 | +4.03 |
Optimix Emerging Markets Fund | OPEMF | Sep 19, 2024 | 59.04 | 0.00 |
Optimix Income Fund | OPTIN | Sep 19, 2024 | 31.45 | 0.00 |
Optimix Mix Fund | OPTMF | Sep 19, 2024 | 37.41 | 0.00 |
PB Holding NV | PBH | Sep 19, 2024 | 2.88 | 0.00 |
Pershing Square Holdings Ltd | PSH | Sep 19, 2024 | 49.40 | +3.24 |
Pharming Group NV | PHARM | Sep 19, 2024 | 0.71 | +0.71 |
Philips KON | PHIA | Sep 19, 2024 | 27.81 | +0.25 |
PostNL NV | PNL | Sep 19, 2024 | 1.23 | +0.82 |
Prosus NV | PRX | Sep 19, 2024 | 34.06 | +4.73 |
Qev N.V. | QEV | Sep 19, 2024 | 9.00 | 0.00 |
Randstad NV | RAND | Sep 19, 2024 | 44.61 | +2.27 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.